June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Adoptive Transfer of Third-Party Plasmacytoid Dendritic Cells Promote Allograft Survival in a Murine Model of Allogeneic Corneal Transplantation
Author Affiliations & Notes
  • Fangfang Qiu
    Center for Translational Ocular Immunology, Department of Ophthalmology, Tufts Medical Center, Boston, Massachusetts, United States
  • Brendan Kenyon
    Center for Translational Ocular Immunology, Department of Ophthalmology, Tufts Medical Center, Boston, Massachusetts, United States
  • Deshea L Harris
    Center for Translational Ocular Immunology, Department of Ophthalmology, Tufts Medical Center, Boston, Massachusetts, United States
  • Pedram Hamrah
    Center for Translational Ocular Immunology, Department of Ophthalmology, Tufts Medical Center, Boston, Massachusetts, United States
    Cornea Service, New England Eye Center; Department of Ophthalmology, Tufts Medical Center, Tufts University School of Medicine, Boston, Massachusetts, United States
  • Footnotes
    Commercial Relationships   Fangfang Qiu None; Brendan Kenyon None; Deshea Harris None; Pedram Hamrah None
  • Footnotes
    Support  NIH-R01-EY029602 (PH), NIH-R01-EY022695(PH), Research to Prevent Blindness Challenge Grant to the department of Ophthalmology, Massachusetts Lions Eye Research Fund, Inc (PH), Tufts Medical Center, Institutional Support (PH), and Eversight (PH).
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 516. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Fangfang Qiu, Brendan Kenyon, Deshea L Harris, Pedram Hamrah; Adoptive Transfer of Third-Party Plasmacytoid Dendritic Cells Promote Allograft Survival in a Murine Model of Allogeneic Corneal Transplantation. Invest. Ophthalmol. Vis. Sci. 2023;64(8):516.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : We have previously demonstrated that adoptively transferred donor-derived plasmacytoid dendritic cells (pDCs) promoted allograft survival in a mouse model of corneal transplantation. Herein, we aimed to determine whether third-party pDCs, the logical and most relevant origin in a clinical setting, have the potential to improve corneal allograft survival, and whether adoptively transferred pDCs home to the sites for allo-sensitization of T cells, which mediate immune rejection, the main cause of graft failure.

Methods : We performed corneal transplantation using BALB/c mice (H2d) recipients and C57BL/6 (H2b) donors. At d1 post-surgery, we sorted splenic pDCs from C3H/HeJ mice (H2k) via flow cytometry, followed by labeling pDCs with CellTrace (CMTMR) and transferring labeled pDCs (2×104) or saline (sham control) to the cornea using fibrin sealant. We performed immunostaining to assess presence of pDCs in the cornea and conjunctiva, and flow cytometry to examine pDCs in ipsilateral draining lymph node (dLNs), spleen, and thymus. Corneas were assessed for 42 days via slit-lamp for neovascularization (NV, 0-8 scale), graft opacity (0-5 scale) and rejection (graft opacity ≥ score 3). We evaluated graft survival by Kaplan-Meier survival curves followed by log-rank test. We performed comparisons using unpaired t-test.

Results : On day 7 after transplantation, only a few CMTMR+pDCs remained in the cornea and to a lesser degree in the conjunctiva. The majority of transferred CMTMR+pDCs (2,000±714.7) were found in dLNs, accounting for 10.0±3.57% of total transferred pDCs. CMTMR+pDCs were also found in the thymus (512.8±61.64 and 2.6±0.31% respectively) and spleen (362.5±70.32 and 1.8±0.35% respectively). Transferred pDCs suppressed corneal NV between d10 to d42 (score 3.1±0.38/mean±SEM to 4.4±0.31, for pDC-treated group vs. 4.0±0.23 to 6.4±0.22, for sham group; p<0.05 for all timepoints), alleviated graft opacity from d14 to d42 (score 1.6±0.22 to 2.0±0.25 vs 1.1±0.21 to 3.8±0.45; all p<0.05), and improved grafts survival (90% vs 37.5%; p=0.010) through the end of 42 days. The effect of third-Party pDCs on allograft survival was comparable to that of donor-specific pDCs (83.3%, p>0.05) previously in this model.

Conclusions : Adoptive transfer of third party allo-pDCs are effective in promoting allograft survival in a murine model of corneal transplantation

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×